CellSensor ARE-bla Hep G2H7D7AH7D7BH7D7CH7D7DHC-04HEP G2insHep-G2 A-1Hep-G2 B-1Hep-G2 C-1Hep-G2 SimpleCell O-GalNAcHep-G2/2.2.1Hep-G2/2.2.15Hep-G2/BGALHep-G2/C3AHep-G2/PGC-1alpha 2x9 mutantHep-G2/PGC-1alpha L2L3 mutantHep-G2/PGC-1alpha wtHep-G2/SFHepAD38HepAD43HepAD79HepBHAe82HepDE19HepDES19HepG2 CYP3A4G/7R clone 87HepG2 hALRHepG2 Tet-Off AdvancedHepG2 Tet-OnHepG2 Tet-On AdvancedHepG2-DM2HepG2-GSHepG2-GS-CYP3A4HepG2-hNTCPHepG2-LucHepG2-luc2HepG2-Red-FLucHepG2-rNTCP-eGFPHepG2-SM1HepG2-WT10
P3432
Initial characterization of the human central proteomeTFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomasDetection of viral proteins in human cells lines by xeno-proteomics: elimination of the last valid excuse for not testing every cellular proteome dataset for viral proteinsThe Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityA genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancersProfiling and authentication of human cell lines using short tandem repeat (STR) loci: Report from the National Cell Bank of Iran.Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomesCharacterization of Human Cancer Cell Lines by Reverse-phase Protein ArraysA comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues.Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.Genetic characteristics of the human hepatic stellate cell line LX-2.Modulating the selectivity of affinity absorbents to multi-phosphopeptides by a competitive substitution strategy.Comparative Proteomic Characterization of 4 Human Liver-Derived Single Cell Culture Models Reveals Significant Variation in the Capacity for Drug Disposition, Bioactivation, and Detoxication.Dynamic DNA methylation across diverse human cell lines and tissuesHigh frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesionsA comprehensive transcriptional portrait of human cancer cell lines.In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes.Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins.Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line.Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.HLA expression in hepatocellular carcinoma cell lines.p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.Cytogenetic studies on human liver cancer cell lines.Hep G2 is a hepatoblastoma-derived cell line.Purification of alpha 1-microglobulin produced by human hepatoma cell lines. Biochemical characterization and comparison with alpha 1-microglobulin synthesized by human hepatocytes.Comparison of protein expression between human livers and the hepatic cell lines HepG2, Hep3B, and Huh7 using SWATH and MRM-HR proteomics: Focusing on drug-metabolizing enzymes.A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping.Selenium-regulated hierarchy of human selenoproteome in cancerous and immortalized cells lines.
P4510
Q54809167-3A171D54-6076-47C7-A610-2C5B53621CA5Q54872220-74CAA7FE-E7B7-4BE7-857A-492AB5819ECEQ54872221-7DCF0069-BF97-4D78-BBB2-56C775665008Q54872223-2C1015E6-3B05-45C6-AB92-4E5562A47BA0Q54872224-FF8C1C4C-B21F-45A7-B572-9EB7857511A8Q54881462-25913AC9-4757-463C-AFD4-0F39824099D2Q54882748-A272020D-3A8D-4205-973C-87AE498DF02FQ54882779-547A0456-4DA5-404B-9BE4-F1901F96063FQ54882780-552AB007-71D9-4F25-A518-CB4FE415C6E9Q54882781-FBF4AB87-D0D2-4F25-8AD8-6165C4160ECBQ54882782-844AF749-230C-4727-A8A4-C54D59A1D82FQ54882786-684343AD-DCEA-4D33-9956-E10982EBF1D8Q54882787-C49866D8-927B-40B8-AC1C-18C93A534B0EQ54882788-D451A5E8-D8F6-439D-9332-1B8A905B6FDCQ54882789-9475D137-3C96-4A64-BD58-954A4AEA01BFQ54882790-2BEAF1F9-D763-41E2-90E2-0BCC2CB3E137Q54882791-B46B3F2C-8EBF-4C79-A72F-21E694BE4104Q54882792-D2ACD21C-F0DB-468C-8C06-8515301AEB84Q54882793-1AF4758E-4A70-4F81-A7E6-E35065B0E72BQ54882829-5473B54C-AAD0-48D5-A0D2-0AD7347EE4AFQ54882830-B6E2C6AD-0243-42B7-B7DB-7EA53778FEADQ54882831-C5A93ED0-0DCC-4F10-BFBE-C30A88ED7B38Q54882837-8A8BAC5F-5F17-489E-9E7A-A5FCCD992DE4Q54882838-3596C914-4EDC-483B-AF8C-54BE0AAE9C54Q54882839-0BB70D2F-209F-4845-9233-B6FB9A8D0D03Q54882844-1618C894-D2CB-4485-8B8E-9D7F6DDD1E3EQ54882845-823B8987-B3BA-49CB-9478-75770E40E7A6Q54882846-D3D3777F-56B8-4397-9FC6-674CE3DEA41EQ54882847-06ACD137-BF72-4D47-86E1-FBB3264989BDQ54882848-8BB77B53-F51A-4629-A31C-1AFE5C0DA4FDQ54882849-ED4C4115-A21D-4B64-AB07-74ADC434BBEBQ54882850-C489AE84-E316-489E-B2F1-DEFAEAAF51CBQ54882851-A9093A4F-65E6-44AA-8469-B66FE087DAC6Q54882852-33C00CE5-8F50-440D-BAC3-C3C9877481A9Q54882853-CA85D449-0595-49F9-B3B9-9C9FD6DB765EQ54882854-125E2BC4-EE13-40EB-B38F-703881F4C792Q54882855-03D86333-407A-4C81-A364-0D1CCFEDAA78Q54882856-2D4FAFFA-735D-4975-BA0F-31D2A78997D3Q54882857-F55E8B5D-9B2C-4D38-910B-22D0CE730A01Q54882858-2A0DDE2F-F0C4-467B-8015-D8DF61C6B8C7
P3432
Q21202777-C4897178-2E31-4F01-8B90-495F1A2A69B0Q28218999-21159A4F-7D0F-4736-A840-48B3986F7969Q28540759-17E43F69-428F-49F0-8E85-9376160DE96AQ29547693-58DD9C0E-13C2-43A3-A9FB-42F7244F2E02Q30434796-0D5BB3A6-139C-4F47-9CE2-E6A4F036EBB1Q33449916-9CA4ABB2-BF0B-4A74-9773-1A73183DDAA5Q33570732-79FE65C0-9CB4-48A9-A418-0CFA09E9925CQ33882864-BD58A95F-6A26-44C0-823F-DD8C8E06543DQ33891043-AAD54AC7-94E9-4813-80CE-4FCE6147A9E2Q34827556-60C60F3D-5530-4C92-8B47-38BB7FD012BBQ35014533-3D33A649-A910-44EB-AEFE-FB849163851AQ36089128-860063A1-FF3B-49F9-A013-3238DFAE3B0BQ36093125-326B0B80-1190-4DF0-A94C-041C77EE4723Q36660155-DC2983DE-4617-4D0F-8B95-E5C061380928Q37064910-ADAE829A-652E-401B-883C-9EB4C4182410Q37854720-9E95D5D2-D360-45C6-8955-52AE3E49DEDFQ38798209-04CC4989-3EE6-4A8F-993C-8E094426F0FDQ39179262-8F75E383-4B43-45BC-9A58-516C235A3C9BQ39406080-E5DDBD1D-9B3F-4441-B4B8-D3E694E1843EQ40298371-E52CDFDA-98D9-4A11-8E11-1AEA4196073EQ40446739-F855D9D3-054A-4DA7-8940-39B8111B56BBQ41450385-20954F33-578F-4084-870D-C7EFCD37B075Q41556197-6B00C8DA-621F-45BD-94B1-3175F7D45926Q41576585-3C3F7490-53C8-4261-B149-DBDBC11CD02BQ42812113-697E7CEE-632D-4460-A706-79CD578DAE81Q42813023-17524F80-7381-4ACC-8345-E9C0F51132D7Q52612153-3151F51E-03DC-4DAC-8A65-9DE6710AD0C7Q53404713-9B509AC6-50D4-4DE3-BCE6-5AF75450ABD0Q53532339-F446D8AC-CC48-457E-A47D-1C0237803B39
P4510
description
Zelllinie
@de
ceall-líne
@ga
cell line
@en
cellijn van een Homo sapiens
@nl
lignée cellulaire
@fr
name
Hep-G2
@de
Hep-G2
@en
Hep-G2
@fr
Hep-G2
@ga
Hep-G2
@nl
HepG2
@ru
hepg2
@fa
type
label
Hep-G2
@de
Hep-G2
@en
Hep-G2
@fr
Hep-G2
@ga
Hep-G2
@nl
HepG2
@ru
hepg2
@fa
altLabel
HEP-G2
@en
Hep G2
@en
HepG2
@en
prefLabel
Hep-G2
@de
Hep-G2
@en
Hep-G2
@fr
Hep-G2
@ga
Hep-G2
@nl
HepG2
@ru
hepg2
@fa